Summary
Our limited understanding of the cellular and molecular basis of the Nervous System, together with the divergent and complex traits of Neurological Disorders, is a major obstacle in finding therapeutic solutions for this group of diseases. At IBMC/i3S, many of the groups developing their work in Neuroscience are focused on neurodegenerative disease, from the identification of disease-causing mechanisms, to drug-discovery and preclinical and clinical studies. The lack of a strong research programme on Basic Neural Cell Biology has been identified by the institute as a major handicap to implement the full potential of the work performed in the field of Neuroscience. Responding to this need, the main objective of NCbio is to recruit and maintain an experienced researcher and research project manager in the field of Neural Cell Biology (ERA Chair Holder), as well as her/his scientific team that will establish a new research group at i3S/IBMC. The Neural Cell Biology research group led by the ERA Chair Holder will provide excellence and trigger innovation in this particular area and will modify the R&I landscape in Neurobiology and Neurologic Disorders at the institute with a positive impact on the region and Portugal. In addition to the structural changes in R&I brought by the ERA Chair Holder, she/he will also help tackle other weaknesses and leverage opportunities IBMC/i3S has, through measures like: • Capacitation of research teams in scientific and in research administration and grant preparation matters, addressing also the technical teams on this latter aspect; • Upgrade of existing IBMC/i3S Doctoral programmes through the creation of a Neural Cell Biology PhD offer; • Engagement of stakeholder communities to help the institute and the external stakeholders achieve higher added value for their activities and results, while positioning IBMC/i3S and its research closer to the market (including the operation of the Neural Cell Biology Stakeholder Hub).
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/951923 |
| Start date: | 01-01-2021 |
| End date: | 31-12-2026 |
| Total budget - Public funding: | 2 479 972,50 Euro - 2 479 972,00 Euro |
Cordis data
Original description
Our limited understanding of the cellular and molecular basis of the Nervous System, together with the divergent and complex traits of Neurological Disorders, is a major obstacle in finding therapeutic solutions for this group of diseases. At IBMC/i3S, many of the groups developing their work in Neuroscience are focused on neurodegenerative disease, from the identification of disease-causing mechanisms, to drug-discovery and preclinical and clinical studies. The lack of a strong research programme on Basic Neural Cell Biology has been identified by the institute as a major handicap to implement the full potential of the work performed in the field of Neuroscience. Responding to this need, the main objective of NCbio is to recruit and maintain an experienced researcher and research project manager in the field of Neural Cell Biology (ERA Chair Holder), as well as her/his scientific team that will establish a new research group at i3S/IBMC. The Neural Cell Biology research group led by the ERA Chair Holder will provide excellence and trigger innovation in this particular area and will modify the R&I landscape in Neurobiology and Neurologic Disorders at the institute with a positive impact on the region and Portugal. In addition to the structural changes in R&I brought by the ERA Chair Holder, she/he will also help tackle other weaknesses and leverage opportunities IBMC/i3S has, through measures like: • Capacitation of research teams in scientific and in research administration and grant preparation matters, addressing also the technical teams on this latter aspect; • Upgrade of existing IBMC/i3S Doctoral programmes through the creation of a Neural Cell Biology PhD offer; • Engagement of stakeholder communities to help the institute and the external stakeholders achieve higher added value for their activities and results, while positioning IBMC/i3S and its research closer to the market (including the operation of the Neural Cell Biology Stakeholder Hub).Status
SIGNEDCall topic
WIDESPREAD-06-2020Update Date
17-05-2024
Images
No images available.
Geographical location(s)
